Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury.  These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.

Pharmaceutical

Invirsa

Robert Shalwitz

Faith V.

Alexandrea M.

Rachael Wingo

Isaiah Shalwitz

Cindy Flinn

The Scientific Advisors at Invirsa provide expert guidance on the development and application of INV-102, ensuring its efficacy in promoting DNA repair and enhancing the innate immune response. They contribute to strategic decisions, oversee research methodologies, and aid in navigating regulatory requirements to advance the compound's clinical progress.

Scientific Advisors

Leadership Team

Scientific Advisors

About

Team members

Other teams at Invirsa

Leadership Team